Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people already taking berberine as a supplement ask whether it is safe to continue once they start Wegovy (semaglutide). There is no published clinical trial that has tested berberine and semaglutide together in humans, so the honest answer is that we do not have direct safety data. Both compounds affect blood-sugar regulation and digestion, which is exactly why the question deserves a careful, clinician-led look rather than a forum reassurance. Wegovy is a prescription-only medicine; a GPhC-registered Independent Prescriber reviews your full medication and supplement list before treatment is approved, including anything like berberine that could interact with its effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Berberine is an alkaloid found in several plants, including barberry and goldenseal. It has been used in traditional Chinese medicine for centuries and has attracted attention in recent years as a so-called "natural Ozempic", a label that spread rapidly on social media and that the MHRA has flagged as misleading. Berberine is not a GLP-1 receptor agonist, and it does not work through the same mechanism as semaglutide.
What berberine does do, according to small studies, is activate an enzyme called AMPK, which influences glucose metabolism and may modestly reduce fasting blood sugar in people with type 2 diabetes. Some studies have reported modest weight reductions, though the trials are generally short, small, and inconsistent. The British National Formulary does not list berberine as a licensed medicine, and it has no MHRA-approved indication. People taking it alongside Wegovy often do so because they believe the effects might complement each other, but that reasoning needs scrutiny.
The overlap in biological pathways is real enough to matter clinically. Both compounds reduce appetite to some degree, both slow how quickly food leaves the stomach, and both influence blood-glucose levels. That is not a reason to assume they are safe in combination; it is a reason to take the question seriously.
Two areas carry the most clinical weight. First, gastrointestinal effects. Semaglutide already produces nausea, loose stools, constipation, and indigestion in a substantial proportion of people, particularly in the first weeks of a new dose. Berberine has its own GI-side-effect profile, diarrhoea and stomach cramps are the most commonly reported. Adding them together may worsen that picture, and whether that combination is manageable depends on the individual. There is no trial that tells us the frequency or severity of combined GI events.
Second, blood-sugar effects. If you have type 2 diabetes or prediabetes and are taking berberine for its glucose-lowering properties, starting semaglutide on top of that introduces a second glucose-lowering influence. For most people without diabetes this is unlikely to cause symptomatic hypoglycaemia, but for those already managing blood sugar carefully (or taking other agents) the combined effect is worth reviewing with a prescriber. The BNF entry for semaglutide lists interactions with other glucose-lowering medicines; berberine is a supplement rather than a licensed drug, so it does not appear in formal interaction databases, but the pharmacological overlap makes it worth flagging.
There is also a subtler point about absorption. Semaglutide delays gastric emptying, which can alter how other orally taken substances are absorbed. Whether this meaningfully changes berberine's bioavailability is unknown, but it is another variable a prescriber will want to factor in.
This is a question our prescribers hear regularly. The short answer is that we do not know, not because there are no theories, but because no one has run the trial. Semaglutide's weight-loss effect in the STEP 1 study, published in the New England Journal of Medicine, involved participants on the medicine alone alongside lifestyle changes. Adding berberine was not part of that protocol.
Some people worry that berberine might blunt Wegovy's effects; others hope it boosts them. Neither concern is supported by human data. What is known is that semaglutide works through a well-characterised GLP-1 receptor pathway, and the clinical trials that led to its MHRA approval (and to private prescription pricing in the UK) did not include berberine as a co-intervention. If you are spending money on both, it is reasonable to ask your prescriber whether the supplement is pulling its weight.
The honest position is this: berberine with semaglutide may be fine for some people, may worsen GI side effects in others, and in people managing blood sugar closely, needs direct clinical review. The absence of trial data is itself useful information. It means a prescriber's judgement, not a supplement label, is the right guide here.
Tell your prescriber. That sounds simple, but people frequently omit supplements when listing what they take, partly because supplements feel different from medicines. For taking berberine with Wegovy specifically, the disclosure matters because of the overlapping effects described above.
At nume, every repeat order is clinically re-reviewed, not rubber-stamped. A prescriber reads your current health picture, including any changes to supplements or other medicines, before the next course is approved. That is the appropriate moment to raise berberine: not after you have already been taking both for six weeks. If you are considering starting Wegovy and currently take berberine, raise it at the initial consultation, you can do that as part of a free eligibility check with our clinical team.
It is also worth knowing that the question of taking berberine and Wegovy together sits alongside broader questions about supplement use on GLP-1 treatment. Some supplements interact with delayed gastric emptying in ways that affect their intended timing. If you take other supplements in the morning on an empty stomach, or timed around meals, that routine may need revisiting once semaglutide is on board. A prescriber or pharmacist can walk through the full list with you.
Finally, a practical note: many people planning to start weight-loss treatment time their order around the start of the month or after payday. Whenever you order, the clinical review happens before dispatch, so that is the moment your supplement question gets a proper answer, built into the process rather than an afterthought. You can also find more general context about how semaglutide works and weight-loss treatment options across our site.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.